MacroGenics | MGNX - Current Assets

Stock Price
4.25
Daily Change
0.09 2.16%
Monthly
24.63%
Yearly
168.99%
Q2 Forecast
4.16

MacroGenics reported $182.52M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
AbbVie USD 33.53B 4.47B Mar/2026
Amgen USD 31.48B 2.42B Mar/2026
AstraZeneca USD 29.61B 890M Mar/2026
Biogen USD 9.19B 216.3M Mar/2026
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
Daiichi Sankyo JPY 2.1T 218.5B Dec/2025
Eli Lilly USD 54.84B 794M Mar/2026
Genmab DKK 2.88B 1.59B Dec/2025
Geron USD 498.53M 21.74M Mar/2026
Gilead Sciences USD 18.64B 1.25B Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
MacroGenics USD 182.52M 37.42M Mar/2026
Merck USD 35.02B 8.5B Mar/2026
Pfizer USD 42.82B 76M Mar/2026
Puma Biotechnology USD 143.58M 7M Sep/2025
Regeneron Pharmaceuticals USD 18.21B 187.3M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Xencor USD 482.85M 116.97M Mar/2026